23159-09-3Relevant articles and documents
INHIBITION OF OLIG2 ACTIVITY
-
Paragraph 00323-00324, (2018/03/25)
Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
-
Page 33, (2008/06/13)
Compounds of formula (I) in free or salt form, wherein R1, R2, R3, and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by mediated by phosphatidylinos
Synthesis of 3-alkyl-2-benzamido-4-hydroxybut-2-enoic acid γ-lactones from alkyl cuprates. Attempted transformation to 2,3-diamino carboxylic acids by hydrogenation and Curtius rearrangement
Olsen,Hennen,Wardle
, p. 4605 - 4611 (2007/10/02)
-